"Designing Growth Strategies is in our DNA"

U.S. Anti-obesity Drugs Market Size, Share, Analysis, By Type (Prescription Drugs and Over-the-counter (OTC) Drugs), By Distribution Channel (Hospital Pharmacy and Retail and Online Pharmacy), and Country Forecast, 2024-2032

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108768

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 26.2% from 2024 to 2032

Unit

Value (USD Billion)

Segmentation

By Type

  • Prescription Drugs
  • Over-the-counter (OTC) Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Retail and Online Pharmacy
U.S. Anti-obesity Drugs Market
  • 2019-2032
  • 2023
  • 2019-2022
  • 60
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports